Stan Wang, Thymmune Therapeutics CEO
September 29, 2023 04:34 AM EDTUpdated September 30, 12:00 AM
Startups

Stem cell start­up Thym­mune lands $37M from Biden's ARPA-H for im­mune-re­ju­ve­nat­ing ther­a­pies

Ryan Cross

Senior Science Correspondent

The Biden ad­min­is­tra­tion is award­ing up to $37 mil­lion to Thym­mune Ther­a­peu­tics, the Ad­vanced Re­search Projects Agency for Health (ARPA-H)

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times